Technology: COVID, Stem cell therapy
Industry: Cell Therapy, Public
Headquarters: Los Angeles, California, United States
Founded Date: 2005-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 8
Total Funding: 66500504
Estimated Revenue: Less than $1M
Last Funding Date: 2019-12-21
Last Funding Type: Post-IPO Equity

Visit Website
info@capricor.com
Register and Claim Ownership